Literature DB >> 23988770

Extensively drug-resistant tuberculosis: early access to bedaquiline for a UK patient.

Clare van Halsema1, Susan Humphreys, Alec Bonington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23988770     DOI： 10.1183/09031936.00128613

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

1.  Network Analysis of Human Genes Influencing Susceptibility to Mycobacterial Infections.

Authors:  Ettie M Lipner; Benjamin J Garcia; Michael Strong
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

2.  First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB.

Authors:  Joseph M Lewis; Paul Hine; Jenny Walker; Saye H Khoo; Miriam Taegtmeyer; S Bertel Squire; Derek J Sloan
Journal:  Eur Respir J       Date:  2016-02-25       Impact factor: 16.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.